Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Fujifilm is now expected to forge ahead in securing regulatory approval in Japan and around the world. The company said it aims to submit a...
In the first study, the combo was found to generate an objective response rate of 21.4% in the treatment of unresectable or advanced melanoma which...
AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance...
Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat those who take them.

Features

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive...

Appointments

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up the mantle of the...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches